University of Wisconsin, Madison
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Wisconsin, Madison sits in the top decile of US sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count).
University of Wisconsin, Madison: 1,039 sponsored US clinical trials, 151 recruiting.
University of Wisconsin, Madison sponsors 1,039 registered US clinical trials on ClinicalTrials.gov, 151 of them currently recruiting, and 712 completed. 98 of these trials are in Phase 3-4 (later-stage) and 251 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 10 trials.
Top-decile sponsor footprint
University of Wisconsin, Madison ranks in the top decile of sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
712 of 824 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,039 total, page 21 of 21
MMF Monotherapy and Immune Regulation in Kidney Transplant Recipients: Part 1 Steroid Withdrawal
NCT00214279
Study of Docetaxel With Doxercalciferol or Placebo for Advanced Prostate Cancer
NCT00582582
Fitness Training in Children
NCT00205296
R-CHOP + GM-CSF for Previously Untreated LCL in Elderly
NCT00582725
Islet Transplantation in Type 1 Diabetic Patients
NCT00214253
Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer
NCT00036790
Airway IgA: Respiratory Tract IgA Levels in Anesthetized Patients Undergoing Elective Surgical Procedures
NCT00205361
Group Therapy for Postpartum Depression
NCT00051246
Interleukin-12 Gene Therapy in Treating Patients With Skin Metastases
NCT00028652
Telephone and Mail Intervention for Alcohol Use Disorders
NCT00204854
Surveillance For New Lung Primaries
NCT00205439
Carotid Atherosclerotic Plaque Study
NCT00214006
Cognitive and Neurophysiological Effects of Raloxifene in Alzheimer's Disease
NCT00065767
Alzheimer's Disease: Therapeutic Potential of Estrogen
NCT00066157
Doxercalciferol Before Surgery in Treating Localized Prostate Cancer
NCT00022412
PS-341 and Doxorubicin in Treating Patients With Advanced Solid Tumors
NCT00023855
Vitamin D Administration in the Nursing Home
NCT00204919
Bupropion SR Plus Counseling for Smoking Cessation
NCT01621009
Tamoxifen Therapy in Amyotrophic Lateral Sclerosis [ALS]
NCT00214110
Bupropion Alone or Combined With Nicotine Gum
NCT01621022
Effect of Olopatadine on Allergic Tear Mediators
NCT00609128
"A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation"
NCT00365846
Phase 2 Hyper-CVAD/Rituximab for Untreated Mantle Cell Lymphoma
NCT00581854
Endostatin in Treating Patients With Advanced Refractory Solid Tumors
NCT00004872
Perifosine in Treating Patients With Advanced Solid Tumors
NCT00005794
The Impact of Cytogam® on Time to Viral Load Reduction in Kidney or Kidney/Pancreas Transplant Recipients With Clinical CMV Disease
NCT00214240
Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer
NCT00213980
Comparison of Patient Outcomes Using Different Delivery Models of Anticoagulation Care
NCT00205400
Does Caffeine Affect the Sensitivity of Adenosine Perfusion Scans?
NCT00205166
Vaccine Therapy With gp100 and/or Sargramostim in Treating Patients With Malignant Melanoma
NCT00003897
Validation of Methods to Estimate Body Fat
NCT00205218
Childhood Origins of Asthma (COAST)
NCT00204841
Perillyl Alcohol in Treating Patients With Metastatic Breast Cancer
NCT00003219
Vitamin D Pilot Study in Patients With Multiple Sclerosis
NCT01257958
Perillyl Alcohol in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
NCT00003238
Vaccine for Recurrent Urinary Tract Infections in Women
NCT00261248
Whole-Body Hyperthermia Plus Chemotherapy in Treating Patients With Advanced Sarcoma
NCT00002974
Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma
NCT00002973
Peer Mentoring for Persons With Spinal Cord Injury (SCI)
NCT00205205
What is open in the University of Wisconsin, Madison pipeline
151 recruiting of 1,039 indexed (15% open); 712 completed (69%).
Phase mix: 98 late (III/IV) vs 251 early (I/II) (early-phase heavy).
Top condition: Healthy (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Wisconsin, Madison: open-pipeline peers nationwide
Peers matched on 1,039 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,039 trials (± recruiting share)
- University of Washington · 1,048 trials · 15% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
- University of Florida · 1,106 trials · 15% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Masonic Cancer Center, University of Minnesota · 14% recruiting · 249 trials
- ModernaTX · 14% recruiting · 90 trials
- United States Naval Medical Center, San Diego · 15% recruiting · 41 trials
- The Cleveland Clinic · 14% recruiting · 688 trials
Related
What to do with this University of Wisconsin, Madison page
1,039 registered trials is a research-attention snapshot, not an endorsement of University of Wisconsin, Madison or any single study.
- 151 of University of Wisconsin, Madison's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition University of Wisconsin, Madison studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Wisconsin, Madison pipeline card: 1,039 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.